Bioventus and MTF Biologics work together to develop the next generation of placental tissue products for knee osteoarthritis

Wednesday, June 12, 2019

Bioventus , the global leader in bone healing solutions, has signed a development cooperation agreement with MTF Biologics, the world's largest organization , to develop The next generation of placental tissue products for the treatment of musculoskeletal pain conditions, the initial focus is knee osteoarthritis (OA). The terms of the agreement were not disclosed.

Tony Bihl, CEO of Bioventus, said: "The development of new bone healing products for osteoarthritis is a core focus of Bioventus. We are pleased to work with MTF Biologics to open the knee OA solution, which will alleviate the symptoms and is expected to be delayed. Progress. As part of this project, we also hope to collaborate on other uses and indications for this product. Promising, growing preclinical and clinical evidence pools highlight the potential of these formulations to support the body's natural healing process. Benefit from the intrinsic growth factors and regulatory molecules present in placental tissue."

MTF Biologics President and CEO Joe Yaccarino said: "MTF Biologics is excited to work with Bioventus to bring this new solution to market. We hope to develop and deliver orthopedic innovations for patients and doctors through this relationship. Biological Products."

About MTF Biologics

MTF Biologics, also known as the Musculoskeletal Transplant Foundation, is a non-profit organization based in Edison, New Jersey. It is a consortium of leading organ collection agencies, organizational restoration agencies, and academic medical institutions. The manager is a group of surgeons who are leading experts in tissue transplantation. MTF Biologics is the world's largest repository of organizations that saves and restores lives by recognizing donations, serving patients and promoting science. Since its inception in 1987, the agency has received more than 132,000 donors and distributed more than 8.6 million transplants. Through its IIAM branch, the agency has arranged more than 58,000 non-portable organs for research. The agency has arranged more than 11.3 million donor referrals through its Statline branch. For further information, please visit www.mtfbiologics.org .

About Bioventus

Bioventus is a bone healing solutions company that provides clinically proven, cost-effective products that help humans heal faster and safer. The company's mission is to help patients recover and enjoy a positive life, thus creating a difference. Bioventus' bone healing products include products for osteoarthritis, surgery and non-surgical bone healing. Based on a commitment to high quality standards, evidence-based medicine and ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, please visit www.BioventusGlobal.com and follow us on Twitter @Bioventusglobal .

Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Disclaimer: The original version of this announcement is an officially licensed version. The translation is for your convenience only. Please refer to the original text. The original version is the only legally valid version.

Contacts
Thomas Hill
919-474-6715
thomas.hill@bioventusglobal.com

AirBridgeCargo - Air frieght solutions for your Pharma Matcon Efficently handling tablets and powders in IBC's Swiss World Cargo - Pharmaceuticals & Healthcare MECO - 90 Years